Medtronic Sprint Fidelis: Four Have Died During Extractions
Washington, DC: Two years after
Medtronic stopped selling the vilified
Sprint Fidelis lead, there is a growing concern as to its continued viability—and while Medtronic and the medical community in general recommend not replacing working leads unless they fail, some doctors are doing just that. [
Read More ]
Failure Rate of Medtronic Sprint Fidelis Lead Could Be Higher
Minneapolis, MN: Patients with the
Medtronic Fidelis Sprint lead, a medical device that connects to the heart and was expected to be effective in 95 percent of patients in spite of a recall two years ago, may be worse off than first thought. A new study suggests that three years after implantation the Sprint Fidelis lead is only expected to remain functional in 88 percent of patients. [
Read More ]
Medtronic Sprint Fidelis Leads Sparked "Extreme Anxiety"
Houston, TX: Patients who have been affected by the 2007
Medtronic Sprint Fidelis lead recall are contacting lawyers to determine whether or not they have a claim against Medtronic. While some people have actually been harmed by fractured Sprint Fidelis leads, others say they constantly live with the fear that their defibrillator will not work as promised, a potentially fatal problem. [
Read More ]
Medtronic estimates that more than two percent of patients fitted with Sprint Fidelis leads will suffer a lead fracture within 30 months of lead implantation. Medtronic will cover the cost of the faulty lead and contribute up to $800 to pay for medical costs not covered by insurance. However, so far the company will not pay for the cost of replacing a lead that has not malfunctioned, meaning that patients who are concerned about a potentially faulty lead will have to pay for the surgery on their own.
